An interventional study of Therapeutic exercise and Pain Neuroscience Education in Chronic Low-back Pain (cLBP), sponsored by Qingdao Municipal Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Qingdao Municipal Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Low Back Pain with a site in China — 17 open to participants now, 19 under way, none of them phase 3. Low Back Pain · China.
Among the 49 studies in Low Back Pain with a site in China, this one is the 29th largest by enrollment of the 42 interventional ones that give a count, is one of 6 that started in 2025, is one of 36 with no phase, and was the 48th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →17 of the 49 studies in Low Back Pain with a site in China are open now. Recruiting first, the newest first:
Chinese PLA General Hospital · Sites in China
Ages 18–80
Beijing Tiantan Hospital · Sites in China
Ages 18–75
Universiti Sains Malaysia · Sites in China
Ages 20–55
Xijing Hospital · Sites in China
Ages 18–65
Xijing Hospital · Sites in China
Ages 18–65
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 1 · Phase 3 2 · Phase 4 2
First in 2008; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is close to the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Median enrollment 84 across the 42 interventional studies, 300 across the 7 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 49 have an industry lead sponsor. The 10 most frequent:
Qingdao Municipal Hospital is the lead sponsor of 5 studies on the registry; none are open to participants now.
Qingdao Municipal Hospital has 1 study filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
3 of the studies in Low Back Pain with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06703671Beijing HospitalElectroacupuncture Treatment for Discogenic Low Back Pain | 2026-12-01 |
| NCT07892846Chinese PLA General HospitalThe Intervention Effect of Exercise on Lumbar Multifidus Muscle Injuries | 2027-05 |
| NCT07858188Nanfang Hospital, Southern Medical UniversityStudy on the Effect of Electronic Moxibustion on Non-Specific Low Back Pain in Young Adults | 2027-09 |
Add all 3 to your calendar (.ics) → With an account.
Among the 49 studies in Low Back Pain with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
### What is this study about?
This study looked at whether adding **pain neuroscience education (PNE)** to standard therapeutic exercise helps people with chronic low back pain who are afraid of moving (a condition called *kinesiophobia*).
### Why does it matter?
Chronic low back pain is the leading cause of disability worldwide. Many people with chronic back pain develop fear of movement, which makes them avoid exercise and can slow down recovery. While exercise is the recommended first-line treatment, fear of movement often reduces how much patients benefit from it.
Pain neuroscience education is a talking therapy that helps patients understand that chronic pain is not always a sign of tissue damage - it often involves the nervous system becoming overly sensitive. The idea is that changing how patients think about pain may reduce their fear and help them engage more fully in exercise.
### What did the researchers do?
Patients with chronic low back pain and high fear of movement were randomly assigned to two groups
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Therapeutic exercise · Behavioral: Pain Neuroscience Education
Behavioral: Therapeutic exercise
\*\*Therapeutic Exercise (TE)\*\* is a structured, supervised program of physical activities designed to improve strength, flexibility, motor control, and functional capacity in patients with musculoskeletal conditions such as chronic low back pain. In this study, the TE program combined three components: motor control exercises (e.g., transversus abdominis and multifidus activation to stabilize the lumbar spine), stretching exercises (e.g., piriformis and erector spinae stretches), and low-intensity aerobic training (daily walking). It was delivered in two supervised face-to-face sessions (at baseline and week 4) with prescribed home exercises performed twice daily, and served as the active control condition that both study groups received-with the experimental group additionally receiving pain neuroscience education.
\*\*Pain Neuroscience Education (PNE)\*\* is a non-pharmacological, educational intervention that helps people with chronic pain reconceptualize their understanding of pain. Through structured discussions and visual materials, a trained therapist explains that chronic pain is often not a reliable sign of ongoing tissue damage but rather a result of heightened nervous system sensitivity, and that psychological factors such as fear, stress, and negative beliefs can amplify pain perception. The goal is to correct misconceptions about pain, reduce fear of movement (kinesiophobia), and encourage patients to engage more fully in exercise and rehabilitation-rather than directly treating pain through manual therapy, medication, or exercise itself.
TSK-17
TSK-17, full name Tampa Scale of Kinesiophobia-17, ranges from 17 to 68, and a higher score indicates worse kinesiophobia.
Time frame: TSK-17 was administered at baseline, 8 weeks, 24 weeks.
Numerical Rating Scale
NRS, full name Numeric Rating Scale, ranges from 0 to 10, and a higher score indicates greater pain intensity.
Time frame: at baseline, 8 weeks, 24 weeks
Roland-Morris Disability Questionnaire
RMDQ, full name Roland-Morris Disability Questionnaire, ranges from 0 to 24, and a higher score indicates more severe low back pain-related disability.
Time frame: at baseline, 8 weeks, 24 weeks
Pain Catastrophizing Scale
PCS, full name Pain Catastrophizing Scale, ranges from 0 to 52, and a higher score indicates stronger pain catastrophizing.
Time frame: at baseline, 8 weeks, 24 weeks
Central Sensitization Inventory
CSI, full name Central Sensitization Inventory, ranges from 0 to 100, and a higher score indicates more prominent central sensitization symptoms.
Time frame: at baseline, 8 weeks, 24 weeks
Fractional amplitude of low-frequency fluctuations
Time frame: at baseline, 8 weeks
regional homogeneity (ReHo)
Time frame: at baseline, 8 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jan 2025 to primary completion in Oct 2025, 9 months.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's 9 months is below that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Qingdao Municipal Hospital